(Q37856301)

24 August 2017

1 reference

title

Drug delivery to the CNS and polymeric nanoparticulate carriers (English)

1 reference

24 August 2017

1 reference

1 reference

1

Luca Costantino

1 reference

24 August 2017

publication date

1 November 2010

1 reference

Future Medicinal Chemistry

24 August 2017

published in

1 reference

24 August 2017

volume

2

1 reference

24 August 2017

issue

11

1 reference

24 August 2017

page(s)

1681-1701

1 reference

Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Blood-brain barrier delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Targeted therapy for neuro-oncology: reviewing the menu

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Structure-brain exposure relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

On the rate and extent of drug delivery to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Blood-brain barrier transport of therapeutics via receptor-mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Delivery of peptides and proteins through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Cell-penetrating peptides: mechanism and kinetics of cargo delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Strategies to improve drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Identification of peptide ligands for targeting to the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood–brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Identification and design of peptides as a new drug delivery system for the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Dendrimers as carriers for delivery of chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Dendrimers: emerging polymers for drug-delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Impact of nanotechnology on drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Potential of solid lipid nanoparticles in brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Lipid nanoparticles for parenteral delivery of actives.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Chapter 3 - Colloidal systems for CNS drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Polymeric nanoparticles for the drug delivery to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Pharmacokinetics and biodistribution of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Size-dependent tissue kinetics of PEG-coated gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticles for drug delivery: the need for precision in reporting particle size parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Physical approaches to biomaterial design

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Role of target geometry in phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Reduction of inflammatory reaction of poly(d,l-lactic-co-glycolic Acid) using demineralized bone particles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Toxicity of therapeutic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Immunological risk of injectable drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Interaction of PLGA nanoparticles with human blood constituents.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Subcellular targeting strategies for drug design and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Polymers and nanoparticles: intelligent tools for intracellular targeting?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Endocytosis of nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Recent approaches to intracellular delivery of drugs and DNA and organelle targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

A methodology to study intracellular distribution of nanoparticles in brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Brain uptake of thiamine-coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

In situ blood-brain barrier transport of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

The fate of biodegradable microspheres injected into rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Raman imaging of PLGA microsphere degradation inside macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

In vitro model for the degradation of alkylcyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Functional protein delivery into neurons using polymeric nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

The uptake and intracellular fate of PLGA nanoparticles in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Potential neurotoxicity of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Prospects of TAT-mediated protein therapy for fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Drug transport to brain with targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Uptake of cationzied albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Delivery of nanoparticles to the brain detected by fluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Influence of polysaccharide coating on the interactions of nanoparticles with biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Plasma Protein Adsorption of Tween 80- and Poloxamer 188-stabilized Solid Lipid Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

An attempt to directly trace polymeric nanoparticles in vivo with electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Intranasal delivery to the central nervous system: mechanisms and experimental considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticles for direct nose-to-brain delivery of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nasal delivery of high molecular weight drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Improving protein therapeutics with sustained-release formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Protein instability in poly(lactic-co-glycolic acid) microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

Formulating protein therapeutics into particulate forms

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.249

21 January 2018

Identifiers

DOI

10.4155/FMC.10.249

1 reference

24 August 2017

1 reference